Home » Topics » Regulatory » Patents

Patents
RSS

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

RPR claims dual-action TNF/cAMP phosphodiesterase inhibitors

Dec. 3, 1996

Pharmacopeia reports protein farnesyl transferase inhibitors

Dec. 3, 1996

New farnesyl protein transferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

Dec. 3, 1996

Merck reveals new thrombin inhibitor series

Dec. 3, 1996

Antiproliferative agents disclosed by Kitasato Institute

Dec. 2, 1996

Antihyperlipidemic agents from natural source described by Takeda

Dec. 2, 1996

Potent ACAT inhibitor discovered by Kitasato Institute

Dec. 2, 1996

Therapeutically active NPY analogues reported by Salk Institute

Dec. 2, 1996

Lilly research into antiobesity proteins continues

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...